MARVF yields 71428.57% · MRK yields 2.76%● Live data
📍 MARVF pulled ahead of the other in Year 1
Combined, MARVF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MARVF + MRK for your $10,000?
Marvel Discovery Corp. engages in the acquisition, exploration, and development of mineral properties in Canada. The company has an option to acquire a 100% interest in the Duhamel Property consists of nine mineral claims covering an area of approximately 500 hectares located northwest of the city of the Saguenay, Quebec; the Wicheeda North project comprises 18 claims that covers 4,423.8 hectares situated Northeast of Prince George, British Columbia; and the Blackfly property that includes five claims consisting of 64 unpatented mining claims located in Atikokan, Ontario. It also has an option to acquire a 100% interest in Slip Gold property consists of six claims with 264 claim units situated in Newfoundland; the Victoria/Long Lake comprises five claims with 53 claim units located in Newfoundland; the East Bull property, which includes 16 mineral claims situated in the Deagle, Gaiashk, and Gerow mining district, Ontario; and the Sandy Pond and Baie Verte Line property comprising 335 mineral claims located in the Province of Newfoundland and Labrador, as well as holds interest in Gander South project comprises 14 mineral claims situated in Newfoundland. In addition, Marvel Discovery Corp. has an option to acquire a 100% interest in the Highway North property consists of five contiguous claims totaling 2,573 hectares located in the Athabasca region of Saskatchewan. The company was formerly known as International Montoro Resources Inc. and changed its name to Marvel Discovery Corp. in February 2021. Marvel Discovery Corp. was incorporated in 1987 and is headquartered in Vancouver, Canada.
Full MARVF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.